Cargando…
Adalimumab-Induced Lupus Nephritis: Case Report and Review of the Literature
Autores principales: | Kazzi, Brigitte, Gudenkauf, Brent, Fine, Derek, Monroy-Trujillo, Jose Manuel, Azar, Antoine, Giannini, Gabriel, Timlin, Homa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medical Research and Education Association
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10176219/ https://www.ncbi.nlm.nih.gov/pubmed/35546334 http://dx.doi.org/10.5152/eurjrheum.2022.21059 |
Ejemplares similares
-
Hyperhomocysteinemia and Lupus Nephritis
por: Timlin, Homa, et al.
Publicado: (2019) -
Experience with abatacept in refractory lupus nephritis
por: Calatayud, Emma, et al.
Publicado: (2023) -
Treatment Using Both Voclosporin and Belimumab in Four Patients With Lupus Nephritis
por: Baum, Rebecca, et al.
Publicado: (2023) -
Comment on the Article “Adalimumab-Induced Lupus Nephritis: Case Report and Review of the Literature”
por: Drosos, Alexandros A., et al.
Publicado: (2023) -
Clinical Outcomes Observed among Biopsy Proven Lupus Nephritis Patients Treated with Mycophenolate Mofetil as First-line Therapy
por: Timlin, Homa, et al.
Publicado: (2017)